Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $3.11M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Nov 10, 2026 · Notice filed Nov 10, 2026
A Roivant Sciences officer told the SEC about a plan to sell $50.7M of Roivant Sciences shares around Nov 10, 2026. The shares were not acquired as compensation. That is 0.2% of all Roivant Sciences shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $3.11M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $21.6M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Roivant Sciences's Reporting person sold $738K of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.